Jefferies Group LLC Ionis Pharmaceuticals Inc Call Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Sep 21, 2023	SELL	$34.54 - $47.25 $4.77 Million - $6.52 Million	-138,000 Reduced 70.05%	59,000 $2.35 Million
Q2 2021 Aug 20, 2021	SELL	$34.54 - $47.25 $202 Million - $276 Million	-5,841,000 Reduced 99.0%	59,000 $2.35 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $197 Million - $269 Million	5,703,000 Added 2894.92%	5,900,000 $2.35 Million
Q1 2021 Sep 21, 2023	BUY	$42.51 - $63.78 $8.37 Million - $12.6 Million	197,000 New	197,000 $8.86 Million
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $7.52 Million - $11.3 Million	177,000 Added 885.0%	197,000 $8.86 Million
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $810,600 - $1.01 Million	20,000 New	20,000 $833,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.